Search results
Showing 2656 to 2670 of 8937 results
Levodopa/carbidopa (ND0612) for Parkinson's Disease [ID6727]
Awaiting development Reference number: GID-TA11954 Expected publication date: TBC
Awaiting development Reference number: GID-TA11932 Expected publication date: TBC
Sepiapterin for treating hyperphenylalaninaemia in phenylketonuria in people of any age [ID6750]
Awaiting development Reference number: GID-TA11982 Expected publication date: TBC
Obinutuzumab for treating primary membranous nephropathy [ID6751]
Awaiting development Reference number: GID-TA11983 Expected publication date: TBC
In development Reference number: GID-TA11963 Expected publication date: TBC
Digital technologies to support self-management of asthma: early value assessment
In development Reference number: GID-HTE10063 Expected publication date: 30 April 2026
In development Reference number: GID-IPG10441 Expected publication date: TBC
Management of vomiting in children and young people with gastroenteritis: ondansetron (ESUOM34)
Summary of the evidence on ondansetron for the management of vomiting in children and young people with acute gastroenteritis
Immune (idiopathic) thrombocytopenic purpura: rituximab (ESUOM35)
Summary of the evidence on rituximab for immune (idiopathic) thrombocytopenic purpura in adults to inform local NHS planning and decision-making
Summary of the evidence on rituximab for treating autoimmune haemolytic anaemia (AIHA) to inform local NHS planning and decision-making
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)
Summary of the evidence on oral magnesium glycerophosphate for preventing recurrent hypomagnesaemia to inform local NHS planning and decision-making
Summary of the evidence on sildenafil for managing digital ulcers to inform local NHS planning and decision-making
Prevention of recurrence of C3 glomerulopathy post-transplant: eculizumab (ESUOM44)
Summary of the evidence on eculizumab to prevent the recurrence of C3 glomerulopathy post-transplant to inform local NHS planning and decision-making
Summary of the evidence on ramipril for relieving the symptoms of peripheral arterial disease (PAD) to inform local NHS planning and decision-making
Summary of the evidence on fluoxetine for treating hypersexuality to inform local NHS planning and decision-making